Yuchun Lee - 25 Jan 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
25 Jan 2023
Net transactions value
-$1,952,054
Form type
4
Filing time
27 Jan 2023, 15:18:18 UTC
Previous filing
25 Jan 2023
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $288,560 +4,000 +213% $72.14 5,875 25 Jan 2023 Direct
transaction VRTX Common Stock Sale $250,240 -800 -14% $312.80 5,075 25 Jan 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale $823,256 -2,621 -52% $314.10 2,454 25 Jan 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale $182,356 -579 -24% $314.95 1,875 25 Jan 2023 Direct F1, F2, F5
transaction VRTX Common Stock Options Exercise $288,560 +4,000 +213% $72.14 5,875 26 Jan 2023 Direct
transaction VRTX Common Stock Sale $95,257 -302 -5.1% $315.42 5,573 26 Jan 2023 Direct F1, F2, F6
transaction VRTX Common Stock Sale $361,175 -1,140 -20% $316.82 4,433 26 Jan 2023 Direct F1, F2, F7
transaction VRTX Common Stock Sale $317,950 -1,000 -23% $317.95 3,433 26 Jan 2023 Direct F1, F2, F8
transaction VRTX Common Stock Sale $152,602 -478 -14% $319.25 2,955 26 Jan 2023 Direct F1, F2, F9
transaction VRTX Common Stock Sale $128,100 -400 -14% $320.25 2,555 26 Jan 2023 Direct F1, F2, F10
transaction VRTX Common Stock Sale $218,239 -680 -27% $320.94 1,875 26 Jan 2023 Direct F1, F2, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4,000 -42% $0.000000 5,429 25 Jan 2023 Common Stock 4,000 $72.14 Direct F12
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4,000 -74% $0.000000 1,429 26 Jan 2023 Common Stock 4,000 $72.14 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06).
F4 Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50).
F5 Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14).
F6 Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66).
F7 Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16).
F8 Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35).
F9 Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56).
F10 Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77).
F11 Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99).
F12 Fully vested.